You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 10,821,074


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,821,074
Title:Sublingual and buccal film compositions
Abstract: The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent.
Inventor(s): Myers; Garry L. (Kingsport, TN), Hilbert; Samuel D. (Jonesboro, TN), Boone; Bill J. (Johnson City, TN), Bogue; B. Arlie (New Carlisle, IN), Sanghvi; Pradeep (Schererville, IN), Hariharan; Madhusudan (Munster, IN)
Assignee: AQUESTIVE THERAPEUTICS, INC. (Warren, NJ)
Application Number:16/048,243
Patent Claim Types:
see list of patent claims
Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,821,074

Introduction to Patents and Patent Scope

Patents are intellectual property rights granted to inventors for their innovative creations, providing exclusive rights to make, use, and sell the invention for a specified period. The scope and claims of a patent are crucial as they define the boundaries of the invention and what is protected under the patent.

What is United States Patent 10,821,074?

To analyze the scope and claims of United States Patent 10,821,074, we first need to identify the patent's subject matter. However, since the specific details of this patent are not provided in the sources, we will discuss the general process and key elements involved in understanding any patent's scope and claims.

Patent Claims

Patent claims are the heart of a patent, as they delineate the invention's boundaries and define what is protected. Here are some key points about patent claims:

Independent and Dependent Claims

  • Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive[3].
  • Dependent claims, on the other hand, refer back to and further limit an independent claim, often adding specific details or features.

Claim Language and Scope

  • The language used in claims is critical. Independent claim length and count can be metrics to measure patent scope. Broader claims may be more susceptible to challenges during the examination process, while narrower claims may have a higher probability of grant and a shorter examination process[3].

Measuring Patent Scope

Metrics for Patent Scope

  • Independent claim length: Longer claims often indicate more complex inventions but may also suggest broader scope.
  • Independent claim count: More claims can indicate a broader scope, but this can also complicate the examination process[3].

Correlates of Patent Scope

  • Patent maintenance payments: Higher maintenance payments may indicate a more valuable and broader patent.
  • Forward citations: The number of times a patent is cited by later patents can indicate its impact and scope.
  • Breadth of patent classes: Patents that span multiple classes may have a broader scope.
  • Novelty: The degree of innovation can also reflect the patent's scope[3].

The Examination Process

Narrowing Claims

  • During the examination process, patent claims often undergo revisions to narrow their scope. This is done to ensure the claims are clear, valid, and not overly broad[3].

Global Dossier and Prior Art

  • Tools like the Global Dossier and Common Citation Document (CCD) help in identifying prior art and related applications, which can influence the scope of the patent claims. These tools provide a comprehensive view of the patent family and citation data, aiding in the examination process[4].

Searching and Analyzing Patents

USPTO Resources

  • The USPTO provides several resources for searching and analyzing patents, including the Patent Public Search tool, Global Dossier, and Patent and Trademark Resource Centers (PTRCs). These resources help in understanding the patent landscape and the scope of individual patents[4].

Public Search Facility

  • The USPTO Public Search Facility in Alexandria, VA, offers access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist in patent searches[4].

Legal and Policy Considerations

Small Claims Patent Court

  • There have been discussions and studies on establishing a small claims patent court to address issues related to patent litigation costs and complexity. This could impact how patent scope and claims are handled in disputes[5].

Case Study: Analyzing Patent 10,821,074

To analyze the specific patent 10,821,074, you would need to:

Retrieve the Patent Document

  • Use the USPTO's Patent Public Search tool or other resources to retrieve the full text of the patent.

Review Claims

  • Carefully read the independent and dependent claims to understand the invention's boundaries.

Examine Prior Art and Citations

  • Use tools like the Global Dossier and CCD to identify prior art and citations that may have influenced the patent's scope.

Assess Scope Metrics

  • Apply metrics such as independent claim length and count to gauge the patent's scope.

Key Takeaways

  • Patent Claims: The claims section is crucial for defining the invention and its boundaries.
  • Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope.
  • Examination Process: The examination process often narrows the scope of patent claims to ensure clarity and validity.
  • USPTO Resources: Utilize USPTO tools like the Patent Public Search and Global Dossier to analyze patents comprehensively.
  • Legal Considerations: Be aware of legal and policy discussions, such as the potential for a small claims patent court, which could impact patent disputes.

FAQs

Q: What is the importance of independent claims in a patent?

  • Independent claims are crucial as they stand alone and define the invention without reference to other claims, providing a broad and comprehensive description of the invention.

Q: How do you measure the scope of a patent?

  • The scope of a patent can be measured using metrics such as independent claim length and count, patent maintenance payments, forward citations, breadth of patent classes, and novelty.

Q: What is the role of the Global Dossier in patent searching?

  • The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users see the patent family, dossier, classification, and citation data for these applications.

Q: Why is the examination process important for patent claims?

  • The examination process is critical as it ensures that patent claims are clear, valid, and not overly broad, often narrowing the scope of claims during this process.

Q: What is the potential impact of a small claims patent court on patent disputes?

  • A small claims patent court could simplify and reduce the costs associated with patent litigation, making it more accessible for smaller entities to resolve patent disputes.

Sources

  1. NCR Investor Relations - "UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K"
  2. USAGov - "U.S. Patent and Trademark Office (USPTO)"
  3. SSRN - "Patent Claims and Patent Scope"
  4. USPTO - "Search for patents"
  5. ACUS - "U.S. Patent Small Claims Court"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,821,074

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-001 May 21, 2020 DISCN Yes No 10,821,074 ⤷  Subscribe Y ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-002 May 21, 2020 DISCN Yes No 10,821,074 ⤷  Subscribe Y ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-003 May 21, 2020 DISCN Yes No 10,821,074 ⤷  Subscribe Y ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-004 May 21, 2020 DISCN Yes No 10,821,074 ⤷  Subscribe Y ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-005 May 21, 2020 DISCN Yes No 10,821,074 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,821,074

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 077803 ⤷  Subscribe
Austria E536868 ⤷  Subscribe
Austria E536869 ⤷  Subscribe
Austria E553746 ⤷  Subscribe
Australia 2002332118 ⤷  Subscribe
Australia 2002348432 ⤷  Subscribe
Australia 2002362772 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.